SYBLEU, Inc. (OTC PINK: SYBE) is a biotechnology company dedicated to developing and marketing therapies for human and animal health, as well as medical devices and clinical diagnostics. We actively pursue strategic acquisitions and in-licensing opportunities to expand our intellectual property portfolio and seek strategic partnerships to bring these technologies to market. With a focus on innovation, we have begun the process of assembling a talented team of senior executives and advisors in order to drive our mission forward.